Delivery Order 75D30124D20037-75D30124F00001
Award Date
9/6/24
Potential Completion Date
9/5/25
Potential Value
$325K
Federal Agency
CDC Pittsburgh
Awardee
Quest Diagnostics Incorporated
Ultimate Awardee
Not listed
NAICS Category
621511 - Medical Laboratories
PSC Category
Q301 - Reference Laboratory Testing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Time and Materials
Place of Performance
Secaucus, NJ 07094, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
5
Legislative Mandate
Service Contract Inventory
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $24,691,200 firm-fixed-price definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Quest Diagnostics Incorporated for serology testing services. The contract has a period of performance through March 5, 2022 and was awarded on November 13, 2020 without any set-aside designation. Quest Diagnostics, a for-profit diagnostic information services provider, has previously supported federal agencies such as the Department of Justice's Bureau of Prisons, the...
This contract was awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Quest Diagnostics Incorporated, a for-profit diagnostic information services provider, for data submission services. The contract is a definitive, firm fixed-price contract with a potential value of $722,500.00. The purpose is to obtain laboratory test order and test result data, including longitudinal patient identifiers but without personally identifiable information, to...
This is a federal contract award to Quest Diagnostics Incorporated, doing business as Quest Diagnostics, by the Centers for Disease Control and Prevention (CDC) for a Test Surge and Data Sharing Multiple Award Indefinite Delivery Indefinite Quantity (IDIQ) contract. The contract has a ceiling value of $3,636,702.00 and an ultimate completion date of September 26, 2029. The contract is for delivery orders and is a Firm Fixed Price type. The contract does not have a set-aside designation. Quest...
This is a $6,631,042.24 Indefinite Delivery Indefinite Quantity (IDIQ) contract awarded to Quest Diagnostics Incorporated by the Centers for Disease Control and Prevention (CDC) to provide test surge and data sharing services. The contract has an ultimate completion date of September 26, 2029. This IDIQ contract is part of the broader "Test Surge and Data Sharing Multiple Award IDIQ" and does not have a set-aside designation. Under this contract, Quest Diagnostics will provide a...
This is a $74,393,160.50 definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Quest Diagnostics Incorporated, a large for-profit diagnostic information services provider. The contract is for COVID-19 genomic sequencing services and has a completion date of April 22, 2025. The contract is a firm-fixed-price type and does not utilize any set-aside designations. Quest Diagnostics has a strong track record of providing reference laboratory testing and diagnostic...
This is a $4,470,182.84 firm fixed-price definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Quest Diagnostics Incorporated, a provider of diagnostic information services. The contract is for "QUEST DIAGNOSTICS DATA" and has a period of performance through March 3, 2025. Quest Diagnostics has previously provided COVID-19 and other infectious disease testing services, as well as reference laboratory testing support, to various federal agencies...
This firm-fixed-price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to Quest Diagnostics Incorporated, doing business as Quest Diagnostics, for a Hepatitis C Prevalence Study. The $1,992,000.00 contract is to conduct a cross-sectional, multi-state assessment of viral hepatitis C prevalence through commercial laboratory testing of stored serum specimens, with a period of performance from September 2023 to September 2024. Quest Diagnostics has provided...
This is a $17,504,850.00 firm fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Quest Diagnostics Nichols Institute, doing business as Quest Diagnostics, for SARS-COV-2 SPHERES baseline genomic sequencing services. The contract does not have a set-aside designation. Quest Diagnostics, a for-profit organization, is the prime contractor performing the work at its San Juan Capistrano, California facility. The contract supports the CDC's disease...
The Centers for Disease Control and Prevention (CDC) awarded a $16,500 purchase order to Quest Diagnostics Incorporated for deidentified Quest serum aliquots. Quest Diagnostics will deliver the aliquots to the CDC location in Halethorpe, Maryland by September 28, 2023 under the firm fixed price contract that began on September 1, 2023. As one of the largest clinical laboratories and medical testing companies in the United States, Quest Diagnostics will utilize its extensive experience and...
This is a $6,343 firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Quest Diagnostics Nichols Institute Inc., doing business as Quest Diagnostics. The contract is for unspecified laboratory functions and does not have a set-aside designation, indicating full and open competition. Quest Diagnostics is a subsidiary of the larger Quest Diagnostics Incorporated, a leading provider of diagnostic information services to the federal...